|
Diabetes, Vol 47, Issue 10 1578-1585, Copyright © 1998 by American Diabetes Association
Complementary action of antioxidant enzymes in the protection of bioengineered insulin-producing RINm5F cells against the toxicity of reactive oxygen species
M Tiedge, S Lortz, R Munday and S Lenzen
Institute of Clinical Biochemistry, Hannover Medical School, Germany.
To determine the importance of different antioxidative enzymes for the
defense status of insulin-producing cells, the effects of stable
overexpression of glutathione peroxidase (Gpx), catalase (Cat), or Cu/Zn
superoxide dismutase (SOD) in insulin-producing RINm5F cells on the
cytotoxicity of hydrogen peroxide (H2O2), hypoxanthine/xanthine oxidase
(H/XO), and menadione have been investigated. Single overexpression of Cat
or Gpx provided less protection than the combined expression of Cat plus
SOD or Cat plus Gpx, while single overexpression of SOD either had no
effect on the toxicity of the test compounds or increased it. RINm5F cells
were also susceptible to butylalloxan, a lipophilic alloxan derivative that
is selectively toxic to pancreatic beta-cells. Overexpression of enzymes,
both alone and in combination, did not protect against butylalloxan-induced
toxicity while SOD overexpression increased it, as evident from a half
maximally effective concentration (EC50) value. The addition of Cat to the
culture medium completely prevented the toxic effects of H2O2 and H/XO but
had no significant effect on the toxicity of menadione or butylalloxan.
Extracellular SOD had no effect on the toxicity of any of the test
compounds. The results of this study show the importance of a combination
of antioxidant enzymes in protecting against the toxicity of reactive
oxygen species. Thus, overexpression of Cat and Gpx, alone or in
combination with SOD, by use of molecular biology techniques can protect
insulin-producing cells against oxidative damage. This may represent a
strategy to protect pancreatic beta-cells against destruction during the
development of autoimmune diabetes and emphasizes the importance of optimal
antioxidative enzyme equipment for protection against free radical-mediated
diseases.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Numazawa, H. Sakaguchi, R. Aoki, T. Taira, and T. Yoshida
Regulation of the susceptibility to oxidative stress by cysteine availability in pancreatic {beta}-cells
Am J Physiol Cell Physiol,
August 1, 2008;
295(2):
C468 - C474.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Poitout and R. P. Robertson
Glucolipotoxicity: Fuel Excess and {beta}-Cell Dysfunction
Endocr. Rev.,
May 1, 2008;
29(3):
351 - 366.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. B. Mysore, T. A. Shinkel, J. Collins, E. J. Salvaris, N. Fisicaro, L. J. Murray-Segal, L. E.A. Johnson, D. A. Lepore, S. N. Walters, R. Stokes, et al.
Overexpression of Glutathione Peroxidase With Two Isoforms of Superoxide Dismutase Protects Mouse Islets From Oxidative Injury and Improves Islet Graft Function
Diabetes,
July 1, 2005;
54(7):
2109 - 2116.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Chen, X. Li, and P. N. Epstein
MnSOD and Catalase Transgenes Demonstrate That Protection of Islets From Oxidative Stress Does Not Alter Cytokine Toxicity
Diabetes,
May 1, 2005;
54(5):
1437 - 1446.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. P. Robertson
Chronic Oxidative Stress as a Central Mechanism for Glucose Toxicity in Pancreatic Islet Beta Cells in Diabetes
J. Biol. Chem.,
October 8, 2004;
279(41):
42351 - 42354.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. P. Olcott, G. Tocco, J. Tian, D. Zekzer, J. Fukuto, L. Ignarro, and D. L. Kaufman
A Salen-Manganese Catalytic Free Radical Scavenger Inhibits Type 1 Diabetes and Islet Allograft Rejection
Diabetes,
October 1, 2004;
53(10):
2574 - 2580.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Gurgul, S. Lortz, M. Tiedge, A. Jorns, and S. Lenzen
Mitochondrial Catalase Overexpression Protects Insulin-Producing Cells Against Toxicity of Reactive Oxygen Species and Proinflammatory Cytokines
Diabetes,
September 1, 2004;
53(9):
2271 - 2280.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. P. Robertson, J. Harmon, P. O. T. Tran, and V. Poitout
{beta}-Cell Glucose Toxicity, Lipotoxicity, and Chronic Oxidative Stress in Type 2 Diabetes
Diabetes,
February 1, 2004;
53(90001):
S119 - 124.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
X. Li, H. Chen, and P. N. Epstein
Metallothionein Protects Islets from Hypoxia and Extends Islet Graft Survival by Scavenging Most Kinds of Reactive Oxygen Species
J. Biol. Chem.,
January 2, 2004;
279(1):
765 - 771.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. P. Robertson, J. Harmon, P. O. Tran, Y. Tanaka, and H. Takahashi
Glucose Toxicity in {beta}-Cells: Type 2 Diabetes, Good Radicals Gone Bad, and the Glutathione Connection
Diabetes,
March 1, 2003;
52(3):
581 - 587.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Evans, I. D. Goldfine, B. A. Maddux, and G. M. Grodsky
Are Oxidative Stress-Activated Signaling Pathways Mediators of Insulin Resistance and {beta}-Cell Dysfunction?
Diabetes,
January 1, 2003;
52(1):
1 - 8.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. K. Azevedo-Martins, S. Lortz, S. Lenzen, R. Curi, D. L. Eizirik, and M. Tiedge
Improvement of the Mitochondrial Antioxidant Defense Status Prevents Cytokine-Induced Nuclear Factor-{kappa}B Activation in Insulin-Producing Cells
Diabetes,
January 1, 2003;
52(1):
93 - 101.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Evans, I. D. Goldfine, B. A. Maddux, and G. M. Grodsky
Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes
Endocr. Rev.,
October 1, 2002;
23(5):
599 - 622.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Piganelli, S. C. Flores, C. Cruz, J. Koepp, I. Batinic-Haberle, J. Crapo, B. Day, R. Kachadourian, R. Young, B. Bradley, et al.
A Metalloporphyrin-Based Superoxide Dismutase Mimic Inhibits Adoptive Transfer of Autoimmune Diabetes by a Diabetogenic T-Cell Clone
Diabetes,
February 1, 2002;
51(2):
347 - 355.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Goth, A. Lenkey, and W. N. Bigler
Blood Catalase Deficiency and Diabetes in Hungary
Diabetes Care,
October 1, 2001;
24(10):
1839 - 1840.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Ilizarov, H.-C. Koo, J. A. Kazzaz, L. L. Mantell, Y. Li, R. Bhapat, S. Pollack, S. Horowitz, and J. M. Davis
Overexpression of Manganese Superoxide Dismutase Protects Lung Epithelial Cells against Oxidant Injury
Am. J. Respir. Cell Mol. Biol.,
April 1, 2001;
24(4):
436 - 441.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. E. Karlsen, D. Pavlovic, K. Nielsen, J. Jensen, H. U. Andersen, F. Pociot, T. Mandrup-Poulsen, D. L. Eizirik, and J. Nerup
Interferon-{gamma} Induces Interleukin-1 Converting Enzyme Expression in Pancreatic Islets by an Interferon Regulatory Factor-1-Dependent Mechanism
J. Clin. Endocrinol. Metab.,
February 1, 2000;
85(2):
830 - 836.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. I. Darville, Y.-S. Ho, and D. L. Eizirik
NF-{kappa}B Is Required for Cytokine-Induced Manganese Superoxide Dismutase Expression in Insulin-Producing Cells
Endocrinology,
January 1, 2000;
141(1):
153 - 162.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1998 by the American Diabetes Association.
|
|
| |
|